Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating promising results in the control of type 2 diabetes. This synthetic peptide resembles the actions of naturally produced GLP-1, a hormone https://neilpskg683192.activosblog.com/37819381/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes